Dimethylarginines in patients with intracerebral hemorrhage: association with outcome, hematoma enlargement, and edema

Dimethylarginines in patients with intracerebral hemorrhage: association with outcome, hematoma enlargement, and edema

Abstract Background Asymmetric dimethylarginine (ADMA)––the most potent endogenous NO-synthase inhibitor, has been regarded as mediator of endothelial dysfunction and oxidative stress. Considering experimental data, levels of ADMA and its structural isomer symmetric dimethylarginine (SDMA) might be...

Full description

Bibliographic Details
Main Authors: Hans Worthmann, Na Li, Jens Martens-Lobenhoffer, Meike Dirks, Ramona Schuppner, Ralf Lichtinghagen, Jan T. Kielstein, Peter Raab, Heinrich Lanfermann, Stefanie M. Bode-Böger, Karin Weissenborn
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Journal of Neuroinflammation
Subjects:
ADMA
SDMA
Intracerebral hemorrhage
Outcome
Hematoma enlargement
Edema
Online Access:http://link.springer.com/article/10.1186/s12974-017-1016-1

Internet

http://link.springer.com/article/10.1186/s12974-017-1016-1

Similar Items